Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (01349.HK)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Shanghai, Shanghai and currently employs 925 full-time employees. The company went IPO on 2002-08-13. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a China-based company mainly engaged in research and development, manufacturing and marketing of biomedicine. The firm's products include aminolevulinic acid hydrochloride topical powder (trade name: ALA) and hemporfin or injection (trade name: FuMeiDa), and doxorubicin hydrochloride liposome injection (trade name: LIBOd), among others. Its products are mainly used for skin venereal disease treatment and anti-tumor treatment. The firm conducts its businesses in the domestic market.